July 31, 2020, 2:26 a.m. EDT

Global RNA Interference (RNAi) Drug Delivery Market Size,Growth 2020 Regional Trend, Future Growth, Leading Players Updates, Industry Demand, Current and Future Plans by Forecast to 2026

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jul 31, 2020 (Profound via COMTEX) -- A recent report provides crucial insights along with application based and forecast information in the Global RNA Interference (RNAi) Drug Delivery Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the RNA Interference (RNAi) Drug Delivery market.

With increasing cases of obesity all over the globe, a need for conducting an in-depth study about this healthcare issue led to the development of this report. Increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, are key market drivers. The report discusses more information about these subjects, with a focus on the rising need for RNA Interference (RNAi) Drug Delivery.

Download Sample - https://www.qyresearchmedical.com/sample/73667

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period. With healthcare being a sensitive topic, a separate analysis is included that discusses the widespread continuing obesity all over the globe consequently increasing demand for surgical devices.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified.

Key Players of the global RNA Interference (RNAi) Drug Delivery market are included as given below:

Metabolic disorders
Alnylam Pharmaceuticals Inc
Merck amp; Co. Inc
Access Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Calondo Pharmaceuticals Inc
Marina Biotech Inc
RXi Pharmaceuticals Corp
Quark Pharmaceuticals Inc
Silence Therapeutics plc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc
Traversa Therapeutics Inc
RNA Interference (RNAi) Drug Delivery Breakdown Data by Type
Nanoparticle Drug Delivery Technology
Pulmonary Drug Delivery Technology
Nucleic Acid Drug Delivery Technology
Aptamer Drug Delivery Technology
RNA Interference (RNAi) Drug Delivery Breakdown Data by Application
Infectious Diseases
Cardiology
Oncology
Neurology
Ophthalmology
Metabolic Disorders

Download Full Report - https://www.qyresearchmedical.com/report/checkout/73667/3500

Reasons to Purchase This Report:

  • Estimates RNA Interference (RNAi) Drug Delivery development trends with SWOT analysis

  • Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players

  • Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion

  • Market dynamics and opportunities for growth for players in the near future

  • Competitive landscape describing the RNA Interference (RNAi) Drug Delivery market revenue shares of key players.

  • Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects

TABLE OF CONTENT

1 Study Coverage
1.1 RNA Interference (RNAi) Drug Delivery Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top RNA Interference (RNAi) Drug Delivery Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global RNA Interference (RNAi) Drug Delivery Market Size Growth Rate by Type
1.4.2 Nanoparticle Drug Delivery Technology
1.4.3 Pulmonary Drug Delivery Technology
1.4.4 Nucleic Acid Drug Delivery Technology
1.4.5 Aptamer Drug Delivery Technology
1.5 Market by Application
1.5.1 Global RNA Interference (RNAi) Drug Delivery Market Size Growth Rate by Application
1.5.2 Infectious Diseases
1.5.3 Cardiology
1.5.4 Oncology
1.5.5 Neurology
1.5.6 Ophthalmology
1.5.7 Metabolic Disorders
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global RNA Interference (RNAi) Drug Delivery Market Size, Estimates and Forecasts
2.1.1 Global RNA Interference (RNAi) Drug Delivery Revenue Estimates and Forecasts 2015-2026
2.1.2 Global RNA Interference (RNAi) Drug Delivery Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global RNA Interference (RNAi) Drug Delivery Production Estimates and Forecasts 2015-2026
2.2 Global RNA Interference (RNAi) Drug Delivery, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global RNA Interference (RNAi) Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global RNA Interference (RNAi) Drug Delivery Manufacturers Geographical Distribution
2.4 Key Trends for RNA Interference (RNAi) Drug Delivery Markets amp; Products
2.5 Primary Interviews with Key RNA Interference (RNAi) Drug Delivery Players (Opinion Leaders)

3 Market Size by Manufacturers
3.1 Global Top RNA Interference (RNAi) Drug Delivery Manufacturers by Production Capacity
3.1.1 Global Top RNA Interference (RNAi) Drug Delivery Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top RNA Interference (RNAi) Drug Delivery Manufacturers by Production (2015-2020)
3.1.3 Global Top RNA Interference (RNAi) Drug Delivery Manufacturers Market Share by Production
3.2 Global Top RNA Interference (RNAi) Drug Delivery Manufacturers by Revenue
3.2.1 Global Top RNA Interference (RNAi) Drug Delivery Manufacturers by Revenue (2015-2020)
3.2.2 Global Top RNA Interference (RNAi) Drug Delivery Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by RNA Interference (RNAi) Drug Delivery Revenue in 2019
3.3 Global RNA Interference (RNAi) Drug Delivery Price by Manufacturers
3.4 Mergers amp; Acquisitions, Expansion Plans

4 RNA Interference (RNAi) Drug Delivery Production by Regions
4.1 Global RNA Interference (RNAi) Drug Delivery Historic Market Facts amp; Figures by Regions
4.1.1 Global Top RNA Interference (RNAi) Drug Delivery Regions by Production (2015-2020)
4.1.2 Global Top RNA Interference (RNAi) Drug Delivery Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America RNA Interference (RNAi) Drug Delivery Production (2015-2020)
4.2.2 North America RNA Interference (RNAi) Drug Delivery Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America RNA Interference (RNAi) Drug Delivery Import amp; Export (2015-2020)
4.3 Europe
4.3.1 Europe RNA Interference (RNAi) Drug Delivery Production (2015-2020)
4.3.2 Europe RNA Interference (RNAi) Drug Delivery Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe RNA Interference (RNAi) Drug Delivery Import amp; Export (2015-2020)
4.4 China
4.4.1 China RNA Interference (RNAi) Drug Delivery Production (2015-2020)
4.4.2 China RNA Interference (RNAi) Drug Delivery Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China RNA Interference (RNAi) Drug Delivery Import amp; Export (2015-2020)
4.5 Japan
4.5.1 Japan RNA Interference (RNAi) Drug Delivery Production (2015-2020)
4.5.2 Japan RNA Interference (RNAi) Drug Delivery Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan RNA Interference (RNAi) Drug Delivery Import amp; Export (2015-2020)

5 RNA Interference (RNAi) Drug Delivery Consumption by Region
5.1 Global Top RNA Interference (RNAi) Drug Delivery Regions by Consumption
5.1.1 Global Top RNA Interference (RNAi) Drug Delivery Regions by Consumption (2015-2020)
5.1.2 Global Top RNA Interference (RNAi) Drug Delivery Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America RNA Interference (RNAi) Drug Delivery Consumption by Application
5.2.2 North America RNA Interference (RNAi) Drug Delivery Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe RNA Interference (RNAi) Drug Delivery Consumption by Application
5.3.2 Europe RNA Interference (RNAi) Drug Delivery Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption by Application
5.4.2 Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central amp; South America
5.5.1 Central amp; South America RNA Interference (RNAi) Drug Delivery Consumption by Application
5.5.2 Central amp; South America RNA Interference (RNAi) Drug Delivery Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa RNA Interference (RNAi) Drug Delivery Consumption by Application
5.6.2 Middle East and Africa RNA Interference (RNAi) Drug Delivery Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E

6 Market Size by Type (2015-2026)
6.1 Global RNA Interference (RNAi) Drug Delivery Market Size by Type (2015-2020)
6.1.1 Global RNA Interference (RNAi) Drug Delivery Production by Type (2015-2020)
6.1.2 Global RNA Interference (RNAi) Drug Delivery Revenue by Type (2015-2020)
6.1.3 RNA Interference (RNAi) Drug Delivery Price by Type (2015-2020)
6.2 Global RNA Interference (RNAi) Drug Delivery Market Forecast by Type (2021-2026)
6.2.1 Global RNA Interference (RNAi) Drug Delivery Production Forecast by Type (2021-2026)
6.2.2 Global RNA Interference (RNAi) Drug Delivery Revenue Forecast by Type (2021-2026)
6.2.3 Global RNA Interference (RNAi) Drug Delivery Price Forecast by Type (2021-2026)
6.3 Global RNA Interference (RNAi) Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)
7.2.1 Global RNA Interference (RNAi) Drug Delivery Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global RNA Interference (RNAi) Drug Delivery Consumption Forecast by Application (2021-2026)

8 Corporate Profiles
8.1 Metabolic disorders
8.1.1 Metabolic disorders Corporation Information
8.1.2 Metabolic disorders Overview
8.1.3 Metabolic disorders Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Metabolic disorders Product Description
8.1.5 Metabolic disorders Related Developments
8.2 Alnylam Pharmaceuticals Inc
8.2.1 Alnylam Pharmaceuticals Inc Corporation Information
8.2.2 Alnylam Pharmaceuticals Inc Overview
8.2.3 Alnylam Pharmaceuticals Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Alnylam Pharmaceuticals Inc Product Description
8.2.5 Alnylam Pharmaceuticals Inc Related Developments
8.3 Merck amp; Co. Inc
8.3.1 Merck amp; Co. Inc Corporation Information
8.3.2 Merck amp; Co. Inc Overview
8.3.3 Merck amp; Co. Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Merck amp; Co. Inc Product Description
8.3.5 Merck amp; Co. Inc Related Developments
8.4 Access Pharmaceuticals Inc
8.4.1 Access Pharmaceuticals Inc Corporation Information
8.4.2 Access Pharmaceuticals Inc Overview
8.4.3 Access Pharmaceuticals Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Access Pharmaceuticals Inc Product Description
8.4.5 Access Pharmaceuticals Inc Related Developments
8.5 Dicerna Pharmaceuticals Inc
8.5.1 Dicerna Pharmaceuticals Inc Corporation Information
8.5.2 Dicerna Pharmaceuticals Inc Overview
8.5.3 Dicerna Pharmaceuticals Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Dicerna Pharmaceuticals Inc Product Description
8.5.5 Dicerna Pharmaceuticals Inc Related Developments
8.6 Calondo Pharmaceuticals Inc
8.6.1 Calondo Pharmaceuticals Inc Corporation Information
8.6.2 Calondo Pharmaceuticals Inc Overview
8.6.3 Calondo Pharmaceuticals Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Calondo Pharmaceuticals Inc Product Description
8.6.5 Calondo Pharmaceuticals Inc Related Developments
8.7 Marina Biotech Inc
8.7.1 Marina Biotech Inc Corporation Information
8.7.2 Marina Biotech Inc Overview
8.7.3 Marina Biotech Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Marina Biotech Inc Product Description
8.7.5 Marina Biotech Inc Related Developments
8.8 RXi Pharmaceuticals Corp
8.8.1 RXi Pharmaceuticals Corp Corporation Information
8.8.2 RXi Pharmaceuticals Corp Overview
8.8.3 RXi Pharmaceuticals Corp Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 RXi Pharmaceuticals Corp Product Description
8.8.5 RXi Pharmaceuticals Corp Related Developments
8.9 Quark Pharmaceuticals Inc
8.9.1 Quark Pharmaceuticals Inc Corporation Information
8.9.2 Quark Pharmaceuticals Inc Overview
8.9.3 Quark Pharmaceuticals Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Quark Pharmaceuticals Inc Product Description
8.9.5 Quark Pharmaceuticals Inc Related Developments
8.10 Silence Therapeutics plc
8.10.1 Silence Therapeutics plc Corporation Information
8.10.2 Silence Therapeutics plc Overview
8.10.3 Silence Therapeutics plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Silence Therapeutics plc Product Description
8.10.5 Silence Therapeutics plc Related Developments
8.11 Tacere Therapeutics Inc
8.11.1 Tacere Therapeutics Inc Corporation Information
8.11.2 Tacere Therapeutics Inc Overview
8.11.3 Tacere Therapeutics Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Tacere Therapeutics Inc Product Description
8.11.5 Tacere Therapeutics Inc Related Developments
8.12 PhaseRx Inc
8.12.1 PhaseRx Inc Corporation Information
8.12.2 PhaseRx Inc Overview
8.12.3 PhaseRx Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 PhaseRx Inc Product Description
8.12.5 PhaseRx Inc Related Developments
8.13 Sirnaomics Inc
8.13.1 Sirnaomics Inc Corporation Information
8.13.2 Sirnaomics Inc Overview
8.13.3 Sirnaomics Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Sirnaomics Inc Product Description
8.13.5 Sirnaomics Inc Related Developments
8.14 Traversa Therapeutics Inc
8.14.1 Traversa Therapeutics Inc Corporation Information
8.14.2 Traversa Therapeutics Inc Overview
8.14.3 Traversa Therapeutics Inc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Traversa Therapeutics Inc Product Description
8.14.5 Traversa Therapeutics Inc Related Developments

9 RNA Interference (RNAi) Drug Delivery Production Forecast by Regions
9.1 Global Top RNA Interference (RNAi) Drug Delivery Regions Forecast by Revenue (2021-2026)
9.2 Global Top RNA Interference (RNAi) Drug Delivery Regions Forecast by Production (2021-2026)
9.3 Key RNA Interference (RNAi) Drug Delivery Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan

10 RNA Interference (RNAi) Drug Delivery Consumption Forecast by Region
10.1 Global RNA Interference (RNAi) Drug Delivery Consumption Forecast by Region (2021-2026)
10.2 North America RNA Interference (RNAi) Drug Delivery Consumption Forecast by Region (2021-2026)
10.3 Europe RNA Interference (RNAi) Drug Delivery Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific RNA Interference (RNAi) Drug Delivery Consumption Forecast by Region (2021-2026)
10.5 Latin America RNA Interference (RNAi) Drug Delivery Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa RNA Interference (RNAi) Drug Delivery Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 RNA Interference (RNAi) Drug Delivery Sales Channels
11.2.2 RNA Interference (RNAi) Drug Delivery Distributors
11.3 RNA Interference (RNAi) Drug Delivery Customers

12 Market Opportunities amp; Challenges, Risks and Influences Factors Analysis
12.1 RNA Interference (RNAi) Drug Delivery Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 RNA Interference (RNAi) Drug Delivery Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global RNA Interference (RNAi) Drug Delivery Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Download Full Report - https://www.qyresearchmedical.com/report/checkout/73667/3500

Contact Us:

QYResearch Medical

URL - http://www.qyresearchmedical.com/

Mailing Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Any Assistance, Email ndash; sales@qyresearchmedical.com

COMTEX_368680922/2630/2020-07-31T02:25:39

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.